149806-47-3Relevant articles and documents
MAP4K4 INHIBITORS
-
Paragraph 00249; 00251, (2020/07/05)
This invention relates to compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these compounds, for example in a method of treatmentof cardiac conditions.In particular, the present invention relates to compounds of formula (I):
The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones.
Willson, Timothy M.,Cobb, Jeffery E.,Cowan, David J.,Wiethe, Robert W.,Correa, Itzela D.,et al.
, p. 665 - 668 (2007/10/03)
The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones.